标题
Advances in biologic and small molecule therapies for hidradenitis suppurativa
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume -, Issue -, Pages 1-20
出版商
Informa UK Limited
发表日期
2022-04-26
DOI
10.1080/14656566.2022.2070429
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effectiveness of Secukinumab in the treatment of moderate–severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real‐life setting
- (2021) S. Ribero et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- A safety review of biologic therapies for the management of hidradenitis suppurativa and unmet needs
- (2021) Zachary E. Holcomb et al. Expert Opinion On Drug Safety
- Bimekizumab versus Adalimumab in Plaque Psoriasis
- (2021) Richard B. Warren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risankizumab effectiveness in a recalcitrant case of hidradenitis suppurativa after anti‐TNF and anti‐ interleukin‐17 failures
- (2021) Raffaele Dante Caposiena Caro et al. Dermatologic Therapy
- Reporting of Thromboembolic Events with JAK Inhibitors: Analysis of the FAERS Database 2010–2019
- (2021) Juliana Setyawan et al. DRUG SAFETY
- Golimumab for the Treatment of Hidradenitis Suppurativa in Patients with Previous TNF-α Treatment Failure
- (2021) Maria del Mar Melendez-Gonzalez et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Tyrosine kinase 2 and Janus kinase‒signal transducer and activator of transcription signaling and inhibition in plaque psoriasis
- (2021) James G. Krueger et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa
- (2021) Sophie Glatt et al. JAMA Dermatology
- Prevalence of Hidradenitis Suppurativa
- (2021) Abdulhadi Jfri et al. JAMA Dermatology
- Efficacy and Safety of Adalimumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa
- (2021) Falk G. Bechara et al. JAMA Surgery
- Clinical efficacy of complement C5a inhibition by IFX‐1 in hidradenitis suppurativa: an open‐label single‐arm trial in patients not eligible for adalimumab
- (2020) E.J. Giamarellos‐Bourboulis et al. BRITISH JOURNAL OF DERMATOLOGY
- A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain
- (2020) Alice Gottlieb et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Secukinumab in the Treatment of Moderate-to-Severe Hidradenitis Suppurativa: Results of an Open-Label Trial
- (2020) Rachel G. Casseres et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- IL‐17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa
- (2020) Jean M. Fletcher et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
- (2020) April W. Armstrong et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Effect of Subcutaneous Brodalumab upon Clinical Disease Activity in Hidradenitis Suppurativa: An Open Label Cohort Study
- (2020) John W. Frew et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Effectiveness of secukinumab in Hidradenitis Suppurativa : an open study (20 cases)
- (2020) Z. Reguiaï et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Weekly Administration of Brodalumab in Hidradenitis Suppurativa: An Open Label Cohort Study
- (2020) J.W. Frew et al. BRITISH JOURNAL OF DERMATOLOGY
- Effectiveness and safety of ustekinumab in patients with hidradenitis suppurativa using intravenous induction
- (2020) Eva M. Sánchez‐Martínez et al. Dermatologic Therapy
- Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System
- (2020) Georgios Kokolakis et al. DERMATOLOGY
- Long‐term analysis of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa: Open‐label phase 3 results
- (2020) Akimichi Morita et al. JOURNAL OF DERMATOLOGY
- Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after anti‐TNF failure
- (2020) E. Marques et al. BRITISH JOURNAL OF DERMATOLOGY
- Treatment of hidradenitis suppurativa with certolizumab pegol during pregnancy
- (2020) Iris Wohlmuth‐Wieser et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- First‐in‐human study demonstrating the safety and clinical efficacy of novel anti‐IL‐17A monoclonal antibody CJM112 in moderate to severe plaque psoriasis
- (2020) M. Kaul et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Selective Tyk2 inhibitors as potential therapeutic agents: a patent review (2015-2018)
- (2019) Xingrui He et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- The Immune System Computes the State of the Body: Crowd Wisdom, Machine Learning, and Immune Cell Reference Repertoires Help Manage Inflammation
- (2019) Irun R. Cohen et al. Frontiers in Immunology
- Open‐label, investigator‐initiated, single‐site exploratory trial evaluating secukinumab, an anti‐interleukin‐17A monoclonal antibody, for patients with moderate‐to‐severe hidradenitis suppurativa
- (2019) L. Prussick et al. BRITISH JOURNAL OF DERMATOLOGY
- Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate‐to‐severe atopic dermatitis
- (2019) G. Yosipovitch et al. BRITISH JOURNAL OF DERMATOLOGY
- Determining the Optimal Dose of Infliximab for Treatment of Hidradenitis Suppurativa
- (2019) Ashley N. Oskardmay et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Safety of selective IL ‐23p19 inhibitors for the treatment of psoriasis
- (2019) J.J. Crowley et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Ustekinumab with Intravenous Infusion: Results in Hidradenitis Suppurativa
- (2019) Jorge Romaní et al. DERMATOLOGY
- Twenty‐four‐week interim analysis from a phase 3 open‐label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa
- (2019) Akimichi Morita et al. JOURNAL OF DERMATOLOGY
- Integrating complement into the molecular pathogenesis of Hidradenitis Suppurativa
- (2019) David Grand et al. EXPERIMENTAL DERMATOLOGY
- High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa
- (2019) Mondana H. Ghias et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Association between hidradenitis suppurativa, depression, anxiety, and suicidality: A systematic review and meta-analysis
- (2019) Kevin R. Patel et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- MABp1 Targeting IL-1α for Moderate to Severe Hidradenitis Suppurativa Not Eligible for Adalimumab: A Randomized Study
- (2018) Theodora Kanni et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Apremilast for moderate hidradenitis suppurativa: results of a randomized controlled trial
- (2018) Allard R.J.V. Vossen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study
- (2018) Christos C. Zouboulis et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The Potential Role of circRNA in Tumor Immunity Regulation and Immunotherapy
- (2018) Zihao Xu et al. Frontiers in Immunology
- Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis
- (2018) Kim Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overview and update on biologic therapy for moderate-to-severe hidradenitis suppurativa
- (2018) Martina L Porter et al. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
- Longitudinal observational study of hidradenitis suppurativa: impact of surgical intervention with adjunctive biologic therapy
- (2017) Victoria K. Shanmugam et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
- (2017) Daniella M. Schwartz et al. NATURE REVIEWS DRUG DISCOVERY
- Canakinumab for Severe Hidradenitis Suppurativa
- (2017) Carine Houriet et al. JAMA Dermatology
- Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum
- (2016) J.L. Blok et al. BRITISH JOURNAL OF DERMATOLOGY
- Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
- (2016) Alexa B. Kimball et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes
- (2016) Torbjörn Kullenberg et al. RHEUMATOLOGY
- Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa
- (2016) Vassiliki Tzanetakou et al. JAMA Dermatology
- Dashboard systems: Pharmacokinetic/pharmacodynamic mediated dose optimization for monoclonal antibodies
- (2015) Diane R. Mould et al. JOURNAL OF CLINICAL PHARMACOLOGY
- HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study
- (2015) A.B. Kimball et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Patient Factors That Increase Infliximab Clearance and Shorten Half-life in Inflammatory Bowel Disease
- (2014) Iris Dotan et al. INFLAMMATORY BOWEL DISEASES
- Tumour Necrosis Factor-alpha and Matrix Metalloproteinase-2 are Expressed Strongly in Hidradenitis Suppurativa
- (2013) E Mozeika et al. ACTA DERMATO-VENEREOLOGICA
- Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa
- (2013) Alexa B. Kimball et al. ANNALS OF INTERNAL MEDICINE
- Four-weekly infliximab in the treatment of severe hidradenitis suppurativa
- (2013) B. Moriarty et al. BRITISH JOURNAL OF DERMATOLOGY
- An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa
- (2013) Kieron S. Leslie et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Tumor necrosis factor-α inhibitor therapy and fetal risk: A systematic literature review
- (2013) Renée M Marchioni WORLD JOURNAL OF GASTROENTEROLOGY
- Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry
- (2012) Gary R Lichtenstein et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease
- (2012) Uma Mahadevan et al. Clinical Gastroenterology and Hepatology
- Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacokinetics-Based Dosing Paradigms
- (2012) I Ordás et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Long-term efficacy of infliximab in hidradenitis suppurativa
- (2012) Sabela Paradela et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa
- (2011) I. Miller et al. BRITISH JOURNAL OF DERMATOLOGY
- Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β
- (2011) H.H. van der Zee et al. BRITISH JOURNAL OF DERMATOLOGY
- Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study
- (2011) H.H. van der Zee et al. BRITISH JOURNAL OF DERMATOLOGY
- Serum albumin concentration: a predictive factor of infliximab pharmacokinetics and clinical response in patients with ulcerative colitis
- (2011) A.A. Fasanmade et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa
- (2011) Christoph Schlapbach et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF
- (2011) Gillian A. Hawker et al. ARTHRITIS CARE & RESEARCH
- Treatment of Hidradenitis Suppurativa With Etanercept Injection
- (2010) David R. Adams et al. ARCHIVES OF DERMATOLOGY
- Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy
- (2010) Monika Arenbergerova et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial
- (2010) Annika Grant et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Transmembrane TNF- : structure, function and interaction with anti-TNF agents
- (2010) T. Horiuchi et al. RHEUMATOLOGY
- Increased Serum Tumour Necrosis Factor- in Hidradenitis Suppurativa Patients: Is There a Basis for Treatment with Anti-Tumour Necrosis Factor- Agents?
- (2009) L Matusiak et al. ACTA DERMATO-VENEREOLOGICA
- A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa
- (2009) Robert A. Lee et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now